Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Breast Cancer Intervention Study

NCT00078832 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00078832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Breast Cancer Intervention Study
Lead sponsor
Queen Mary University of London
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2003
Completion date
May 31, 2021
Enrollment
3,864 (actual)
Sites
74

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer